CTIC - CTI BioPharma Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-29,320-40,670-52,009-119,422
Operating Activities, Cash Flows Provided By or Used In
Depreciation593717831990
Adjustments To Net Income1,4196,666-17,14015,383
Changes In Accounts Receivables4402-1561,555
Changes In Liabilities462-3,940-4,0963,450
Changes In Inventories-1,120567-402
Changes In Other Operating Activities-13,507-3,754-4,8912,853
Total Cash Flow From Operating Activities-39,824-39,296-76,680-95,203
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-33-49-137-78
Investments-30,457111111
Other Cash flows from Investing Activities-111111
Total Cash Flows From Investing Activities-30,490-38-137-78
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-444-3,577-5,45238,083
Other Cash Flows from Financing Activities-268-26-1,559-62
Total Cash Flows From Financing Activities63,49138,979-7,366152,017
Effect Of Exchange Rate Changes44-4293513
Change In Cash and Cash Equivalents-6,779-784-84,18057,249